The Food and Drug Administration approved a drug this month that cuts the risk of severe reactions in children and adults exposed to trace amounts of peanuts, tree nuts, milk, dairy and other food allergens — a move that could dramatically improve quality of life for people coping with these risks. The results of the clinical trial supporting the decision were published on Sunday.
New Protection For Patients With Allergies Has High Costs